Literature DB >> 30785464

A concise synthesis and biological study of evodiamine and its analogues.

Jie-Dan Deng1, Shuai Lei, Yi Jiang, Hong-Hua Zhang, Xiao-Ling Hu, Huai-Xiu Wen, Wen Tan, Zhen Wang.   

Abstract

Efficient access to evodiamine and its analogues is presented via Lewis acid catalysis. In this reaction, three chemical bonds and two heterocyclic-fused rings are constructed in one step. The reaction shows good functional group tolerance and atom economy, and various heteroatom-containing evodiamine analogues are obtained in moderate to excellent yields even on a gram scale. An anti-tumor study in vitro demonstrates compound 2b possesses potent efficacy against hepatoma cell line (IC50 = 5.7 μM).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30785464     DOI: 10.1039/c9cc00434c

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  2 in total

1.  Evodiamine inhibits vasculogenic mimicry in HCT116 cells by suppressing hypoxia-inducible factor 1-alpha-mediated angiogenesis.

Authors:  Di Zeng; Peng Zhou; Rong Jiang; Xiao-Peng Li; Shi-Ying Huang; Dan-Yang Li; Guo-Li Li; Li-Sha Li; Shuang Zhao; Ling Hu; Jian-Hua Ran; Di-Long Chen; Ya-Ping Wang; Jing Li
Journal:  Anticancer Drugs       Date:  2021-03-01       Impact factor: 2.389

2.  Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis.

Authors:  Ze-Bo Jiang; Ju-Min Huang; Ya-Jia Xie; Yi- Zhong Zhang; Chan Chang; Huan-Ling Lai; Wenjun Wang; Xiao-Jun Yao; Xing-Xing Fan; Qi-Biao Wu; Chun Xie; Mei-Fang Wang; Elaine Lai-Han Leung
Journal:  J Exp Clin Cancer Res       Date:  2020-11-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.